GSK Pharmaceuticals India: net assets 2022 | Statista
GlaxoSmithKline Pharma Q2 net up 3% to Rs 193 cr, revenue down to Rs 906 cr
Are GSK's legal troubles a threat to the firm's survival? | MoneyWeek
Why GSK should turn down Unilever's billions | MoneyWeek
GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022
GSK to boost spending power of pharma business post break-up
GlaxoSmithKline CEO Walmsley's pay falls to $9.7M as pandemic drags on profits | Fierce Pharma
GSK's drugs arm to get $11 bln booster from consumer spin-off | Reuters
GSK delivers FY 2021 reported sales of £34 billion, stable at AER, +5% CER; Total EPS 87.6p -24% AER, -13% CER and Adjusted EPS of 113.2p -2% AER, +9% CER | GSK
GSK plc - Wikipedia
GlaxoSmithKline : Top 20 Pharmaceutical Companies in 2021 | Contract Pharma
GSK India reports Rs 133 crore net profit in quarter four of FY23 - The Economic Times
Clouds Are Gathering (Again) For GSK | Seeking Alpha
GlaxoSmithKline Deal for Tesaro: It's the Wrong Medicine - Bloomberg
GlaxoSmithKline (GSK): What Could Give Us An Upside Here | Seeking Alpha
GSK: cash flow 2022 | Statista
GSK lines up Rs 6,400cr open offer - Times of India
Financial Ratio Analysis of AstraZeneca and GlaxoSmithKline
Academic Researchers Escape Scrutiny in Glaxo Fraud Settlement
GSK shown up by AstraZeneca yet again | Financial Times
First female CEO of GSK to be paid 25% less than her male predecessor
GSK Stock Price and Chart — LSE:GSK — TradingView
GlaxoSmithKline: 30% Undervalued And Spinoff To Drive Growth (NYSE:GSK) | Seeking Alpha
GSK India reports Rs 133 crore net profit in quarter four of FY23 - The Economic Times
